Breast Cancer Trial, Recruiting NCT06813053 Sponsor: University of Colorado, Denver Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT06813053
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women aged 18 to 100 years old
  • People who speak English
  • People diagnosed with breast cancer at an early to intermediate stage (stage 0 through stage III)
  • People whose medical team has determined that both lumpectomy (removal of the tumour only) and mastectomy (removal of the whole breast) are suitable surgical options for them

Who may not be able to join:

  • People who have already had a surgical consultation about their breast cancer treatment options
  • People who have had breast cancer before
  • People who need chemotherapy treatment before surgery

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sarah Tevis, MD, University of Colorado, Denver

Phone: 1-719-751-8466

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
21 July 2025
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Assess the feasibility of prospectively providing a novel DA to early stage breast cancer patients; Evaluate how well patients receive the decision aid

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov